1. Home
  2. MEI vs LCTX Comparison

MEI vs LCTX Comparison

Compare MEI & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MEI
  • LCTX
  • Stock Information
  • Founded
  • MEI 1946
  • LCTX 1990
  • Country
  • MEI United States
  • LCTX United States
  • Employees
  • MEI N/A
  • LCTX N/A
  • Industry
  • MEI Electrical Products
  • LCTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MEI Technology
  • LCTX Health Care
  • Exchange
  • MEI Nasdaq
  • LCTX Nasdaq
  • Market Cap
  • MEI 256.0M
  • LCTX 274.0M
  • IPO Year
  • MEI N/A
  • LCTX N/A
  • Fundamental
  • Price
  • MEI $7.26
  • LCTX $1.75
  • Analyst Decision
  • MEI Buy
  • LCTX Strong Buy
  • Analyst Count
  • MEI 2
  • LCTX 4
  • Target Price
  • MEI $11.25
  • LCTX $4.25
  • AVG Volume (30 Days)
  • MEI 279.3K
  • LCTX 1.8M
  • Earning Date
  • MEI 12-04-2025
  • LCTX 11-13-2025
  • Dividend Yield
  • MEI 3.87%
  • LCTX N/A
  • EPS Growth
  • MEI N/A
  • LCTX N/A
  • EPS
  • MEI N/A
  • LCTX N/A
  • Revenue
  • MEI $1,030,100,000.00
  • LCTX $10,914,000.00
  • Revenue This Year
  • MEI N/A
  • LCTX N/A
  • Revenue Next Year
  • MEI $3.41
  • LCTX $176.00
  • P/E Ratio
  • MEI N/A
  • LCTX N/A
  • Revenue Growth
  • MEI N/A
  • LCTX 76.43
  • 52 Week Low
  • MEI $5.08
  • LCTX $0.37
  • 52 Week High
  • MEI $17.45
  • LCTX $1.85
  • Technical
  • Relative Strength Index (RSI)
  • MEI 47.24
  • LCTX 60.37
  • Support Level
  • MEI $6.93
  • LCTX $1.53
  • Resistance Level
  • MEI $7.42
  • LCTX $1.72
  • Average True Range (ATR)
  • MEI 0.28
  • LCTX 0.11
  • MACD
  • MEI -0.01
  • LCTX -0.02
  • Stochastic Oscillator
  • MEI 59.40
  • LCTX 65.59

About MEI Methode Electronics Inc.

Methode Electronics Inc supplier of custom-engineered solutions with sales, engineering, and manufacturing locations in North America, Europe, the Middle East, and Asia. It designs, engineers, and produces mechatronic products for Original Equipment Manufacturers (OEMs) utilizing a broad range of technologies for user interface, light-emitting diode (LED) lighting systems, power distribution, and sensor applications. The firm is organized into various business segments: Automotive, Industrial, Interface, and Medical. The Automotive segment, which generates maximum revenue, supplies electronic and electro-mechanical devices and related products to automobiles, including overhead and center consoles, hidden and ergonomic switches, insert molded components, LED-based lighting, and sensors.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

Share on Social Networks: